Andere talen NGM Biopharmaceuticals, Inc.

Aandelen

NGM

US62921N1054

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 04-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,54 ^USD	-1,28%		0,00%	+79,28%

05/04	The Column Group, LLC heeft de overname afgerond van 74% belang in NGM Biopharmaceuticals, Inc. (NasdaqGS:NGM) van andere groep aandeelhouders.	CI
12/03	NGM BIOPHARMACEUTICALS, INC. : Raymond James verlaagt advies naar Neutraal	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NGM Bio Announces Closing of Tender Offer	05/04
NGM Biopharmaceuticals, Inc.(NasdaqGM:NGM) dropped from NASDAQ Composite Index	05/04
The Column Group, LLC completed the acquisition of 74% stake in NGM Biopharmaceuticals, Inc. from other group of shareholders.	05/04
NGM Biopharmaceuticals, Inc.(NasdaqGS:NGM) dropped from S&P Global BMI Index	05/04
NGM Biopharmaceuticals, Inc.(NasdaqGS:NGM) dropped from S&P TMI Index	05/04
NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting	19/03
North American Morning Briefing : Investors -2-	18/03
NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM	13/03
North American Morning Briefing : Stock Futures -2-	13/03
NGM Biopharmaceuticals: Q4 Earnings Snapshot	11/03
NGM Biopharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results	11/03
NGM Biopharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	11/03
North American Morning Briefing : Stock Futures -2-	11/03
North American Morning Briefing : Fed's Preferred -2-	29/02
NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM	27/02
Sector Update: Health Care Stocks Ease Late Afternoon	26/02
Sector Update: Health Care Stocks Weaker Monday Afternoon	26/02
Sector Update: Health Care	26/02
NGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NGM Biopharmaceuticals, Inc. Is Fair to Shareholders	26/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NGM Biopharmaceuticals, Inc.

Aandelen

NGM

US62921N1054

Andere talen

Filters